Working in this direction we demonstrated that XPO1 RNAi interference or chemical inhibition by XPO1 specific small molecule drugs could re-align tumor suppressive microRNAs leading to inhibition of pancreatic cellular growth [38]. The gene discussed is XPO1; the disease is neoplasm.